The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX® formulated delayed-release mesalamine
Crossref DOI link: https://doi.org/10.1007/s11136-014-0797-2
Published Online: 2014-09-06
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yarlas, Aaron
Yen, Linnette
Hodgkins, Paul
License valid from 2014-09-06